In ER+ early-stage breast cancer
The only robust, validated tool to help with clinical
decision-making for extended endocrine treatment
  • Predictive for likelihood of benefit from extended endocrine therapy
  • Prognostic for risk of late distant recurrence
Actionable genomic information for accurate
diagnosis and treatment of metastatic cancer

CancerTYPE ID and CancerTREATMENT NGS+